vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and WEST BANCORPORATION INC (WTBA). Click either name above to swap in a different company.
AbCellera Biologics Inc. is the larger business by last-quarter revenue ($44.9M vs $26.9M, roughly 1.7× WEST BANCORPORATION INC). WEST BANCORPORATION INC runs the higher net margin — 39.2% vs -19.9%, a 59.2% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs 16.6%). WEST BANCORPORATION INC produced more free cash flow last quarter ($12.4M vs $-44.6M). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs 17.3%).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
West Bancorporation Inc. is a regional financial holding company headquartered in the U.S. Midwest, primarily serving markets across Iowa and Minnesota. It provides a full suite of personal and commercial banking services, including deposit accounts, mortgage loans, business lending, and wealth management solutions for individual consumers, small-to-medium enterprises, and local organizational clients.
ABCL vs WTBA — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $26.9M |
| Net Profit | $-8.9M | $10.6M |
| Gross Margin | — | — |
| Operating Margin | -63.7% | 50.0% |
| Net Margin | -19.9% | 39.2% |
| Revenue YoY | 788.4% | 16.6% |
| Net Profit YoY | 73.9% | 34.8% |
| EPS (diluted) | $-0.03 | $0.61 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $26.9M | ||
| Q4 25 | $44.9M | $24.2M | ||
| Q3 25 | $9.0M | $25.0M | ||
| Q2 25 | $17.1M | $23.8M | ||
| Q1 25 | $4.2M | $23.1M | ||
| Q4 24 | $5.0M | $20.9M | ||
| Q3 24 | $6.5M | $20.3M | ||
| Q2 24 | $7.3M | $19.6M |
| Q1 26 | — | $10.6M | ||
| Q4 25 | $-8.9M | $7.4M | ||
| Q3 25 | $-57.1M | $9.3M | ||
| Q2 25 | $-34.7M | $8.0M | ||
| Q1 25 | $-45.6M | $7.8M | ||
| Q4 24 | — | $7.1M | ||
| Q3 24 | $-51.1M | $6.0M | ||
| Q2 24 | $-36.9M | $5.2M |
| Q1 26 | — | 50.0% | ||
| Q4 25 | -63.7% | 39.6% | ||
| Q3 25 | -851.8% | 45.8% | ||
| Q2 25 | -290.2% | 43.4% | ||
| Q1 25 | -1479.6% | 43.4% | ||
| Q4 24 | — | 30.9% | ||
| Q3 24 | -1439.4% | 36.6% | ||
| Q2 24 | -1276.2% | 32.6% |
| Q1 26 | — | 39.2% | ||
| Q4 25 | -19.9% | 30.7% | ||
| Q3 25 | -637.8% | 37.3% | ||
| Q2 25 | -203.3% | 33.5% | ||
| Q1 25 | -1077.2% | 34.0% | ||
| Q4 24 | — | 34.0% | ||
| Q3 24 | -785.4% | 29.3% | ||
| Q2 24 | -504.3% | 26.5% |
| Q1 26 | — | $0.61 | ||
| Q4 25 | $-0.03 | $0.44 | ||
| Q3 25 | $-0.19 | $0.55 | ||
| Q2 25 | $-0.12 | $0.47 | ||
| Q1 25 | $-0.15 | $0.46 | ||
| Q4 24 | — | $0.41 | ||
| Q3 24 | $-0.17 | $0.35 | ||
| Q2 24 | $-0.13 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | $362.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $966.9M | $270.7M |
| Total Assets | $1.4B | $4.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $362.0M | ||
| Q4 25 | $128.5M | $471.1M | ||
| Q3 25 | $83.2M | $232.9M | ||
| Q2 25 | $92.4M | $345.2M | ||
| Q1 25 | $159.3M | — | ||
| Q4 24 | $156.3M | $243.5M | ||
| Q3 24 | $126.6M | — | ||
| Q2 24 | $148.3M | — |
| Q1 26 | — | $270.7M | ||
| Q4 25 | $966.9M | $266.0M | ||
| Q3 25 | $964.0M | $255.1M | ||
| Q2 25 | $1.0B | $240.9M | ||
| Q1 25 | $1.0B | $237.9M | ||
| Q4 24 | $1.1B | $227.9M | ||
| Q3 24 | $1.1B | $235.4M | ||
| Q2 24 | $1.1B | $223.9M |
| Q1 26 | — | $4.0B | ||
| Q4 25 | $1.4B | $4.1B | ||
| Q3 25 | $1.4B | $4.0B | ||
| Q2 25 | $1.4B | $4.1B | ||
| Q1 25 | $1.3B | $4.0B | ||
| Q4 24 | $1.4B | $4.0B | ||
| Q3 24 | $1.4B | $4.0B | ||
| Q2 24 | $1.4B | $4.0B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | $12.9M |
| Free Cash FlowOCF − Capex | $-44.6M | $12.4M |
| FCF MarginFCF / Revenue | -99.4% | 46.0% |
| Capex IntensityCapex / Revenue | 21.9% | 1.8% |
| Cash ConversionOCF / Net Profit | — | 1.22× |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | $79.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $12.9M | ||
| Q4 25 | $-34.7M | $46.5M | ||
| Q3 25 | $-52.6M | $11.4M | ||
| Q2 25 | $-32.4M | $13.5M | ||
| Q1 25 | $-11.6M | $9.7M | ||
| Q4 24 | $-108.6M | $39.8M | ||
| Q3 24 | $-28.9M | $12.9M | ||
| Q2 24 | $-30.0M | $10.0M |
| Q1 26 | — | $12.4M | ||
| Q4 25 | $-44.6M | $43.2M | ||
| Q3 25 | $-61.5M | $10.8M | ||
| Q2 25 | $-45.8M | $12.8M | ||
| Q1 25 | $-22.2M | $8.3M | ||
| Q4 24 | $-187.0M | $13.7M | ||
| Q3 24 | $-47.4M | $7.0M | ||
| Q2 24 | $-50.1M | $2.7M |
| Q1 26 | — | 46.0% | ||
| Q4 25 | -99.4% | 178.3% | ||
| Q3 25 | -687.0% | 43.0% | ||
| Q2 25 | -267.9% | 53.6% | ||
| Q1 25 | -524.0% | 35.7% | ||
| Q4 24 | -3702.8% | 65.6% | ||
| Q3 24 | -728.4% | 34.2% | ||
| Q2 24 | -683.8% | 14.0% |
| Q1 26 | — | 1.8% | ||
| Q4 25 | 21.9% | 13.7% | ||
| Q3 25 | 99.7% | 2.6% | ||
| Q2 25 | 78.2% | 3.2% | ||
| Q1 25 | 251.1% | 6.5% | ||
| Q4 24 | 1552.7% | 125.3% | ||
| Q3 24 | 284.6% | 29.4% | ||
| Q2 24 | 274.6% | 37.1% |
| Q1 26 | — | 1.22× | ||
| Q4 25 | — | 6.26× | ||
| Q3 25 | — | 1.23× | ||
| Q2 25 | — | 1.70× | ||
| Q1 25 | — | 1.24× | ||
| Q4 24 | — | 5.61× | ||
| Q3 24 | — | 2.17× | ||
| Q2 24 | — | 1.93× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
